Related Experiment Video
Updated: Aug 7, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
Published on: January 2, 2026
Management of Serous Cystadenoma
Jon M Harrison1, Carlos Fernandez-Del Castillo2
1Section of Hepatobiliary and Pancreatic Surgery, Division of Surgical Oncology, Department of General Surgery, Massachusetts General Hospital, Boston, USA.
Serous cystadenomas (SCAs) are benign pancreatic tumors. Improved imaging diagnostics are needed to prevent misdiagnosis and unnecessary surgeries for these non-cancerous growths.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Diagnostic Imaging
Background:
- Serous cystadenomas (SCAs) are benign pancreatic neoplasms.
- Resection is typically reserved for symptomatic cases.
- Radiographic variability often complicates diagnosis.
Purpose of the Study:
- To highlight diagnostic challenges associated with SCAs.
- To emphasize the need for improved diagnostic modalities.
- To reduce misdiagnosis rates and unwarranted surgical interventions.
Main Methods:
- Review of existing literature on SCAs.
- Analysis of radiographic presentations and diagnostic pitfalls.
- Discussion of current diagnostic limitations.
Main Results:
- SCAs are frequently misdiagnosed as mucinous cysts or other cystic pancreatic lesions.
- Radiographic features can mimic other pathologies, leading to diagnostic uncertainty.
- Current diagnostic methods are insufficient for definitive preoperative differentiation.
Conclusions:
- Enhanced diagnostic tools are crucial for accurate SCA identification.
- Improved diagnostics will minimize unnecessary resections for benign SCAs.
- Targeted surgical intervention for SCAs should be based on definitive indications.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Urologic Endoscopic Procedure: Cystoscopic Examination

